Company / Depreciation & Amortization
Altimmune, Inc. Depreciation & Amortization History
FY2011-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$477.0K
FY2024
5-year range
$400.0K / $493.0K
FY2020-FY2024
Trend
-3.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has fluctuated over the past 9 years, ranging from $63,109 in FY2017 to $1M in FY2011.
Based on SEC 10-K filings.
$477,000 in FY2024 with a 5-year CAGR of +16.9%.
Increased from $400,000 to $477,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2024, depreciation & amortization decreased 3.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2011.
- Lowest depreciation & amortization in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $477.0K | -3.2% |
| FY2023 | $493.0K | +23.3% |
| FY2022 | $400.0K | -6.7% |
| FY2021 | $428.9K | +10.7% |
| FY2020 | $387.3K | +77.1% |
| FY2019 | $218.7K | +160.9% |
| FY2018 | $83.8K | +32.8% |
| FY2017 | $63.1K | -93.8% |
| FY2011 | $1.0M | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026